U.S. Markets close in 2 hrs, 32 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 9,841.92 | -483.46 | -4.68% |
| NASDAQ | 1,834.31 | -113.08 | -5.81% |
| S&P 500 | 1,041.68 | -57.55 | -5.24% |
Specialty-Health
Below Average
| Prev. Nav 10/2/08 | 12.45 | |
|---|---|---|
| Current Offer | 13.01 | |
|
YTD Return 8/31/08
|
-9.96% | |
|
Total Assets
|
52.8 M |
| 52-Wk Low | 12.32 | |
|---|---|---|
| 52-Wk High | 15.46 | |
| Range | 3.14 |
The investment seeks long-term growth of capital.
The fund normally invests at least 80% of assets in equity securities issued by companies principally engaged in health care and health care-related industries. It invests in securities of a smaller number of companies, usually about 25 to 45 companies. The fund may invest in new, smaller or less-seasoned companies as well as in larger, established companies in Health Care Industries.
| Name | % of Total Fund Assets | |
|---|---|---|
| Alcon, Inc (ACL) | 7.6 % | |
| Teva Pharmaceutical Industries, Ltd. ADR (TEVA) | 7.37 % | |
| Gilead Sciences, Inc (GILD) | 6.57 % | |
| Roche Holding Ltd () | 6.4 % | |
| Genentech, Inc (DNA) | 5.48 % | |
| View All Holdings | ||
Specialty-Health
Below Average
